Condensed Consolidated Statements of Changes in Members' Equity and Stockholders' Equity - USD ($)
$ in Thousands |
Total |
Class A [Member] |
Class B [Member] |
Common Stock [Member]
Class A [Member]
|
Common Stock [Member]
Class B [Member]
|
Additional Paid-in capital [Member] |
Retained Earnings [Member] |
Non-Controlling Interests [Member] |
| Beginning Balance at Dec. 31, 2024 |
$ 149,976
|
|
|
$ 9
|
$ 54
|
$ 125,484
|
$ 17,124
|
$ 7,305
|
| Beginning Balance (Shares) at Dec. 31, 2024 |
|
|
|
9,200,000
|
54,087,158
|
|
|
|
| Contributions |
135
|
|
|
|
|
|
|
135
|
| Distributions |
(135)
|
|
|
|
|
|
|
(135)
|
| Net income attributable to Guardian Pharmacy Services, Inc. |
9,448
|
|
|
|
|
|
9,448
|
|
| Net income (loss) attributable to non-controlling interest |
(175)
|
|
|
|
|
|
|
(175)
|
| Share-based compensation forfeitures (Shares) |
|
|
|
0
|
(516)
|
|
|
|
| Share-based compensation forfeitures |
(1)
|
|
|
|
|
(1)
|
|
|
| Share-based compensation expense |
3,969
|
|
|
|
|
3,969
|
|
|
| Conversion of Guardian Pharmacy, LLC common units into Class B common stock of Guardian Pharmacy Services, Inc. (Shares) |
|
|
|
13,519,946
|
(13,519,946)
|
|
|
|
| Conversion of Guardian Pharmacy, LLC common units into Class B common stock of Guardian Pharmacy Services, Inc. |
|
|
|
$ 14
|
$ (14)
|
|
|
|
| Ending Balance at Mar. 31, 2025 |
163,217
|
|
|
$ 23
|
$ 40
|
129,452
|
26,572
|
7,130
|
| Ending Balance (Shares) at Mar. 31, 2025 |
|
|
|
22,719,946
|
40,566,696
|
|
|
|
| Beginning Balance at Dec. 31, 2024 |
149,976
|
|
|
$ 9
|
$ 54
|
125,484
|
17,124
|
7,305
|
| Beginning Balance (Shares) at Dec. 31, 2024 |
|
|
|
9,200,000
|
54,087,158
|
|
|
|
| Net income attributable to Guardian Pharmacy Services, Inc. |
18,478
|
$ 4,805
|
$ 13,673
|
|
|
|
|
|
| Net income (loss) attributable to non-controlling interest |
(378)
|
|
|
|
|
|
|
|
| Ending Balance at Jun. 30, 2025 |
179,671
|
|
|
$ 23
|
$ 40
|
133,898
|
35,602
|
10,108
|
| Ending Balance (Shares) at Jun. 30, 2025 |
|
|
|
22,730,591
|
40,566,494
|
|
|
|
| Beginning Balance at Dec. 31, 2024 |
149,976
|
|
|
$ 9
|
$ 54
|
125,484
|
17,124
|
7,305
|
| Beginning Balance (Shares) at Dec. 31, 2024 |
|
|
|
9,200,000
|
54,087,158
|
|
|
|
| Ending Balance at Dec. 31, 2025 |
217,924
|
|
|
$ 36
|
$ 27
|
139,353
|
66,343
|
12,165
|
| Ending Balance (Shares) at Dec. 31, 2025 |
|
|
|
36,253,744
|
27,066,890
|
|
|
|
| Beginning Balance at Mar. 31, 2025 |
163,217
|
|
|
$ 23
|
$ 40
|
129,452
|
26,572
|
7,130
|
| Beginning Balance (Shares) at Mar. 31, 2025 |
|
|
|
22,719,946
|
40,566,696
|
|
|
|
| Contributions |
1,094
|
|
|
|
|
|
|
1,094
|
| Distributions |
(54)
|
|
|
|
|
|
|
(54)
|
| Non-cash equity contribution |
2,141
|
|
|
|
|
|
|
2,141
|
| Net income attributable to Guardian Pharmacy Services, Inc. |
9,030
|
3,262
|
5,768
|
|
|
|
9,030
|
|
| Net income (loss) attributable to non-controlling interest |
(203)
|
|
|
|
|
|
|
(203)
|
| Share-based compensation forfeitures (Shares) |
|
|
|
(68)
|
(202)
|
|
|
|
| Share-based compensation forfeitures |
(1)
|
|
|
|
|
(1)
|
|
|
| Share-based compensation expense |
4,447
|
|
|
|
|
4,447
|
|
|
| Issuance of common stock associated with vested restricted stock units (Shares) |
|
|
|
10,713
|
|
|
|
|
| Ending Balance at Jun. 30, 2025 |
179,671
|
|
|
$ 23
|
$ 40
|
133,898
|
35,602
|
10,108
|
| Ending Balance (Shares) at Jun. 30, 2025 |
|
|
|
22,730,591
|
40,566,494
|
|
|
|
| Beginning Balance at Dec. 31, 2025 |
217,924
|
|
|
$ 36
|
$ 27
|
139,353
|
66,343
|
12,165
|
| Beginning Balance (Shares) at Dec. 31, 2025 |
|
|
|
36,253,744
|
27,066,890
|
|
|
|
| Contributions |
79
|
|
|
|
|
|
|
79
|
| Distributions |
(960)
|
|
|
|
|
|
|
(960)
|
| Net income attributable to Guardian Pharmacy Services, Inc. |
13,295
|
|
|
|
|
|
13,295
|
|
| Net income (loss) attributable to non-controlling interest |
249
|
|
|
|
|
|
|
249
|
| Share-based compensation forfeitures (Shares) |
|
|
|
0
|
0
|
|
|
|
| Share-based compensation forfeitures |
(47)
|
|
|
|
|
(47)
|
|
|
| Share-based compensation expense |
1,794
|
|
|
|
|
1,794
|
|
|
| Conversion of Guardian Pharmacy, LLC common units into Class B common stock of Guardian Pharmacy Services, Inc. (Shares) |
|
|
|
13,527,437
|
(13,527,437)
|
|
|
|
| Conversion of Guardian Pharmacy, LLC common units into Class B common stock of Guardian Pharmacy Services, Inc. |
|
|
|
$ 14
|
$ (14)
|
|
|
|
| Stockholders' Equity, Other |
90
|
|
|
|
|
90
|
|
|
| Ending Balance at Mar. 31, 2026 |
232,424
|
|
|
$ 50
|
$ 13
|
141,190
|
79,638
|
11,533
|
| Ending Balance (Shares) at Mar. 31, 2026 |
|
|
|
49,781,181
|
13,539,453
|
|
|
|
| Beginning Balance at Dec. 31, 2025 |
217,924
|
|
|
$ 36
|
$ 27
|
139,353
|
66,343
|
12,165
|
| Beginning Balance (Shares) at Dec. 31, 2025 |
|
|
|
36,253,744
|
27,066,890
|
|
|
|
| Net income attributable to Guardian Pharmacy Services, Inc. |
35,167
|
24,078
|
11,089
|
|
|
|
|
|
| Net income (loss) attributable to non-controlling interest |
498
|
|
|
|
|
|
|
|
| Ending Balance at Jun. 30, 2026 |
257,642
|
|
|
$ 50
|
$ 13
|
144,040
|
101,510
|
12,029
|
| Ending Balance (Shares) at Jun. 30, 2026 |
|
|
|
49,792,884
|
13,539,453
|
|
|
|
| Beginning Balance at Mar. 31, 2026 |
232,424
|
|
|
$ 50
|
$ 13
|
141,190
|
79,638
|
11,533
|
| Beginning Balance (Shares) at Mar. 31, 2026 |
|
|
|
49,781,181
|
13,539,453
|
|
|
|
| Contributions |
574
|
|
|
|
|
|
|
574
|
| Distributions |
(327)
|
|
|
|
|
|
|
(327)
|
| Net income attributable to Guardian Pharmacy Services, Inc. |
21,872
|
$ 17,196
|
$ 4,676
|
|
|
|
21,872
|
|
| Net income (loss) attributable to non-controlling interest |
249
|
|
|
|
|
|
|
249
|
| Share-based compensation forfeitures (Shares) |
|
|
|
0
|
0
|
|
|
|
| Share-based compensation forfeitures |
(48)
|
|
|
|
|
(48)
|
|
|
| Share-based compensation expense |
2,898
|
|
|
|
|
2,898
|
|
|
| Issuance of common stock associated with vested restricted stock units (Shares) |
|
|
|
11,703
|
|
|
|
|
| Ending Balance at Jun. 30, 2026 |
$ 257,642
|
|
|
$ 50
|
$ 13
|
$ 144,040
|
$ 101,510
|
$ 12,029
|
| Ending Balance (Shares) at Jun. 30, 2026 |
|
|
|
49,792,884
|
13,539,453
|
|
|
|